Alovudine

DB06198InvestigationalSmall molecule

Investigated for use/treatment in HIV infection.

Chemical structure of Alovudine
Primary indication
Investigated for use/treatment in HIV infection.Curator reviewed
Formula / weight
C10H13FN2O4 · 244.222 g/mol (avg)
Code names
CL-184,824 · MIV-310 · NSC-140025

Resolves to

Compound
UNIIPG53R0DWDQCAS25526-93-6ChEMBLCHEMBL105318
Structure
InChIKeyUXCAQJAQSWSNPQ-XLPZGREQSA-NSMILESCC1=CN([C@H]2C[C@H](F)[C@@H](CO)O2)C(=O)NC1=O
Targets
P03366gag-polQ72547pol

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
14Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Alovudine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In